{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-002240","form_type":"8-K","ticker":"EXPO","cik":"0000851520","company_name":"EXPONENT INC","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.146540+00:00","generated_at":"2026-06-03T08:55:14.095432+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Exponent Q1 revs before reimbursements up 6.6% to $137.2M, EPS $0.59, raises FY guidance","bullets":["Total revenues $144.9M (+3.3% YoY); net income $30.1M ($0.59 diluted EPS) vs $29.1M ($0.56).","EBITDA margin improved to 29.2% ($40.1M) from 27.8% ($35.8M); utilization 75%.","Engineering segment (84% of rev) grew 8% in rev before reimbursements; environmental/health (16%) grew 1%.","Q2 2024 guidance: rev before reimbursements flat to low-single-digit growth; EBITDA margin 27.25%-28.25%.","FY2024 guidance raised: low-single-digit revenue growth, EBITDA margin 26.25%-27.0% (increased from prior range)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-002240","json":"https://secwatch.observer/filing/0001171843-24-002240.json","markdown":"https://secwatch.observer/filing/0001171843-24-002240.md","text":"https://secwatch.observer/filing/0001171843-24-002240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/851520/000117184324002240/0001171843-24-002240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/851520/000117184324002240/f8k_042524.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T08:55:14.095432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bba132ea26ff42ec74c6ca4403ddfdb0c73d55b4","claim":"EXPONENT INC reported first quarter of fiscal year 2024 ended March 29, 2024 results: revenue $144.9 million, net income $30.1 million, EPS $0.59 per diluted share. Guidance raised.","evidence_excerpt":"Total revenues and revenues before reimbursements for the first quarter of 2024 increased 3.3% to $144.9 million and 6.6% to $137.2 million, respectively, as compared to $140.3 million and $128.7 million in the first quarter of 2023, respectively. Net income increased to $30.1 million, or $0.59 per diluted share, in the first quarter of 2024, as compared to $29.1 million, or $0.56 per diluted share, in the same period of 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/851520/000117184324002240/0001171843-24-002240-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of fiscal year 2024 ended March 29, 2024"},{"label":"Revenue","value":"$144.9 million"},{"label":"Net income","value":"$30.1 million"},{"label":"EPS","value":"$0.59 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}